Uric Acid-to-HDL Cholesterol Ratio as an Independent Predictor of In-Hospital New-Onset Atrial Fibrillation in Non-ST-Elevation Myocardial Infarction
Journal of Clinical Medicine · 14.04.2026 · 15 (8) · 2977
DOI: 10.3390/jcm15082977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.04.2026. Verfasst von Mehmet Nail Bilen und 13 weiteren Autor:innen. Beteiligte Einrichtung: İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi, 34480 Istanbul, Turkey. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
To investigate the association between the uric acid-to-high-density lipoprotein cholesterol ratio (UAHDLr) and the risk of new-onset atrial fibrillation (NOAF) during hospitalization in patients with non-ST-elevation myocardial infarction (NSTEMI).
Methods
This retrospective cohort study included NSTEMI patients without prior atrial fibrillation. UAHDLr was log2-transformed to evaluate the effect of doubling. Feature selection was performed using least absolute shrinkage and selection operator regression. Cox proportional hazards models with sequential adjustments were applied. Nonlinear associations were assessed using restricted cubic spline analysis, and discrimination was evaluated with time-dependent receiver operating characteristic analysis.
Results
UAHDLr was independently associated with in-hospital NOAF across all models. Doubling (1-unit increase) UAHDLr significantly increased NOAF risk in unadjusted (HR: 5.97, 95% CI: 3.71–9.61) and clinically adjusted models (HR: 5.98, 95% CI: 3.58–9.99). The association was stronger in the LASSO-adjusted (HR: 8.19, 95% CI: 4.13–16.24) and fully adjusted models (HR: 13.40, 95% CI: 5.90–30.44). Spline analysis showed a progressive increase in NOAF risk with higher UAHDLr values. Discrimination was stable, with an area under the curve of approximately 0.76.
Conclusions
UAHDLr is a strong, easily accessible biomarker for predicting in-hospital NOAF in NSTEMI patients and may support early risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi, 34480 Istanbul, Turkey.
ORCID-Profile: Ömer Genç, Muhammed Mert Göksu, Hüseyin Akgün, Gamze Acar, Ufuk Sali Halil, Yusuf İnci, Ersin İbişoğlu
Zitieren
APA
Bilen, M. N., Genç, Ö., Çapar, G., Göksu, M. M., Akgün, H., Acar, G., Özdoğan, G. C., Üredi, G., Şen, F., Halil, U. S., İnci, Y., Tekin, D. D. N., Er, F., & İbişoğlu, E. (2026). Uric Acid-to-HDL Cholesterol Ratio as an Independent Predictor of In-Hospital New-Onset Atrial Fibrillation in Non-ST-Elevation Myocardial Infarction. Journal of Clinical Medicine, 15(8), 2977. https://doi.org/10.3390/jcm15082977
Vancouver
Bilen MN, Genç Ö, Çapar G, Göksu MM, Akgün H, Acar G, et al. Uric Acid-to-HDL Cholesterol Ratio as an Independent Predictor of In-Hospital New-Onset Atrial Fibrillation in Non-ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 2026;15(8):2977. doi:10.3390/jcm15082977
BibTeX
@article{Bilen2026,
author = {Bilen, Mehmet Nail and Genç, Ömer and Çapar, Gazi and Göksu, Muhammed Mert and Akgün, Hüseyin and Acar, Gamze and Özdoğan, Göksenin Cansu and Üredi, Günseli and Şen, Furkan and Halil, Ufuk Sali and İnci, Yusuf and Tekin, Deniz Dilan Naki and Er, Fahri and İbişoğlu, Ersin},
title = {Uric Acid-to-HDL Cholesterol Ratio as an Independent Predictor of In-Hospital New-Onset Atrial Fibrillation in Non-ST-Elevation Myocardial Infarction},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {2977},
doi = {10.3390/jcm15082977}
}
EUVIMED